Risedronate Sodium and Tirofiban Hydrochloride-Reference-Cited by-同舟云学术

Risedronate Sodium and Tirofiban Hydrochloride

Published:1999-02 Issue:2 Volume:34 Page:207-231
ISSN:0018-5787
Container-title:Hospital Pharmacy
language:en
Short-container-title:Hosp Pharm

Author:

Levien Terri¹,Baker Danial E.²

Affiliation:

1. Drug Information Pharmacist; Washington State University at Spokane, 601 West First Avenue, Spokane, WA 99201-3899

2. Drug Information Center, and College of Pharmacy, Washington State University at Spokane, 601 West First Avenue, Spokane, WA 99201-3899. The original editor of these monographs was Dennis J. Cada, PharmD, from The Formulary.

Abstract

Each month, subscribers to The Formulary® receive print and electronic versions of at least six monographs reviewing new drug entities or related drugs within a category. Some reviews take a second look at currently available drugs, whereas other preliminarily evaluate agents about to be released—just in time for use with your Pharmacy and Therapeutics Committee or for counter detailing. The monographs are prepared by clinical and drug-information pharmacists and are reviewed by expert pharmacists and physicians. Through the cooperation of The Formulary, Hospital Pharmacy has arranged to publish selected reviews in this column. If you would like more information about The Formulary or its related electronic bulletin board, known as the F.I.X.® (Formulary Information Exchange, write to: The Formulary, 33971 Selva Road, Suite 250, Dana Point CA 92629; or call 1-800-322–4349.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Link

http://journals.sagepub.com/doi/pdf/10.1177/001857879903400208

Reference15 articles.

1. Actonel package literature. Procter and Gamble Pharmaceuticals; March 1998.